Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients

Transplantation
D MutimerE Elias

Abstract

Complications of the biliary anastomosis are the principal cause of clinically serious bacterial sepsis in liver transplant recipients. Reported series suggest an association of bacterial and fungal infection with cytomegalovirus (CMV) infection, although the mechanism of this association is unclear. We examined the association of serious bacterial sepsis with CMV replication in a cohort of 106 consecutive liver transplant recipients. Sequentially collected buffy coats were examined with a polymerase chain reaction (PCR) assay that has been shown to have good predictive value for the development of CMV infection. For selected patients, CMV-specific IgM response and serum tumor necrosis factor-alpha (TNF-alpha) were also measured. Ten of 13 patients with serious bacterial sepsis developed buffy coat PCR positivity, compared with 26 of 93 patients without bacterial sepsis (chi-square, P<0.001). Ten of 10 septic recipients with a seropositive liver donor developed PCR positivity. For 9 of 10 recipients, bacterial sepsis developed before PCR positivity. Bacterial sepsis was associated with high serum levels of TNF-alpha. Immune response to CMV (reflected by the appearance CMV-specific IgM) was apparently affected by bacterial sepsi...Continue Reading

References

Apr 1, 1988·Journal of Medical Virology·O BronstherA Tzakis
Aug 5, 1982·The New England Journal of Medicine·R J UnwinS L Lightman
Jan 1, 1995·Transplant International : Official Journal of the European Society for Organ Transplantation·E MorC M Miller
Jan 29, 1994·Lancet·W D DöckeH D Volk

❮ Previous
Next ❯

Citations

Oct 4, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mary Hummel, Michael M Abecassis
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C V Paya
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Singh
Aug 16, 2000·Clinical Nuclear Medicine·F Morin, I Côté
May 25, 2001·Critical Care Medicine·A HeiningerK Hamprecht
Jul 9, 2003·Critical Care Medicine·Charles H CookRonald M Ferguson
Mar 27, 1999·Oral Microbiology and Immunology·A Contreras, J Slots
Sep 18, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Toru AraiSeiji Hayashi
Sep 16, 2004·Journal of Virology·Sara GredmarkCecilia Söderberg-Nauclér
Nov 28, 2002·Biological Chemistry·Susanna PröschHans-Dieter Volk
Apr 3, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R H Rubin
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·P ReinkeH D Volk
Aug 12, 2009·Infectious Disease Clinics of North America·Peter K Linden
Jun 24, 2004·Oral Microbiology and Immunology·J Slots
Jun 30, 2005·Transplant Infectious Disease : an Official Journal of the Transplantation Society·B-H TanQ Ahmed
Jun 30, 2005·Transplant Infectious Disease : an Official Journal of the Transplantation Society·H KomatsuK Tanaka
May 26, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Nina SinghThomas V Cacciarelli
Apr 28, 2005·Periodontology 2000·Jørgen Slots
May 25, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·P Martín-DávilaS Moreno
Oct 28, 2016·Transplant International : Official Journal of the European Society for Organ Transplantation·Víctor VinuesaDavid Navarro
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sara GredmarkCecilia Söderberg-Nauclér

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R N HusniT Kirby
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
W van der Bij, R Speich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A S KutzaG Bein
Proceedings of the National Academy of Sciences of the United States of America
M E PenfoldT J Schall
© 2021 Meta ULC. All rights reserved